FDA issued a Warning Letter to Cantrell Drug Company on 1/21/2015 for a previous inspection.
483 Cantrell Drug Company Mar 2018

483 Cantrell Drug Company Mar 2018

Scott Ballard FDA, Camerson Moore FDA, Sara Rothman FDA$119.00 - Available Now

FDA investigators audited the Cantrell Drug Company - Little Rock, AR, United States facility and issued inspectional observations (via FDA 483) on 22 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Mar 2018
  • Location: Little Rock, United States
  • FEI: 3004483441
Add To Cart